These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8983763)

  • 21. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dimethyl sulfoxide in the therapy of vibration disease].
    Kolesov VG; Barskiĭ VD
    Gig Tr Prof Zabol; 1989; (11):17-21. PubMed ID: 2612922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
    Martsevich SIu; Sementsov DP; Kutishenko NP; Alimova EV
    Ter Arkh; 2001; 73(9):42-6. PubMed ID: 11642080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Calcium antagonists in ischemic heart disease].
    Sadowski Z; Kośmicki M; Skorykow-Sapińska A
    Kardiol Pol; 1987; 30 Suppl():44-9. PubMed ID: 3454384
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential therapy with calcium antagonists. Hemodynamic studies using nifedipine, verapamil and diltiazem].
    Lehmann HU; Hochrein H
    Dtsch Med Wochenschr; 1985 Apr; 110(17):674-80. PubMed ID: 3987531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal mechanisms of peripheral neuropathy in vibration disease].
    Kolesov VG; Rusanova DV; Lakhman OL; Lizarev AV
    Med Tr Prom Ekol; 2005; (10):16-21. PubMed ID: 16315585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morpho-functional changes of erythrocytes in vibration disease].
    Shpagina LA; Loseva MI; Sukharevskaia TM
    Gig Tr Prof Zabol; 1990; (4):30-2. PubMed ID: 2376340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical use of calcium channel blockers.
    Galle JS
    Conn Med; 1983 Oct; 47(10):605-10. PubMed ID: 6627936
    [No Abstract]   [Full Text] [Related]  

  • 31. [Disorders of main stress effector parameters under effects of local vibration].
    Davydova NS; Lizarev AV; Abramatets EA; Ivanskaia TI
    Med Tr Prom Ekol; 2003; (3):32-5. PubMed ID: 12723241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Achard JM; Oudart N; Aldigier JC
    Lancet; 2000 Dec; 356(9245):1926-7; author reply 1928-9. PubMed ID: 11130401
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and hemodynamic effects of diltiazem in patients with arterial hypertension associated with ischemic heart disease].
    Bychko MV
    Lik Sprava; 2007; (1-2):50-5. PubMed ID: 17682517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The comparative effect of calcium antagonists on hemodynamics in patients with a stable form of essential hypertension (a randomized study)].
    Belousov IuB; Akhadov ShV; Volkov MG
    Ter Arkh; 1994; 66(3):72-7. PubMed ID: 8202859
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effort angina and calcium antagonists].
    Parenti GF; Colombo G; Favini G; De Vita C
    Minerva Cardioangiol; 1988; 36(7-8):351-6. PubMed ID: 3062487
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of local and overall vibration on bone mineral density and phosphorus and calcium metabolism].
    Verbovoĭ AF
    Gig Sanit; 2001; (6):42-4. PubMed ID: 11810906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assessment of time-dependent effects of long-acting altiazem in patients with hypertension stage II].
    Beliaev SD; Khetagurova LG; Zaslavskaia RM
    Klin Med (Mosk); 2002; 80(3):62-6. PubMed ID: 11980164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the factors providing the oxygen regimen to tissues in miners with vibration disease receiving combined therapy with a course of hyperbaric oxygenation].
    Soboleva NP
    Vrach Delo; 1989 Jul; (7):106-7. PubMed ID: 2800478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.